Hydroxychloroquine is an agent used as a treatment but also considered as a prophylaxis for SARS-CoV-2 infection. We report the case of a patient who developed COVID-19 while on hydroxychloroquine for mixed connectivitis associated with spondyloarthritis. Although more work is needed before any conclusions can be drawn, this raises questions about the protective role of this drug against infection. Are they really protected against COVID-19 or will they develop pauci-symptomatic forms?
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608760 | PMC |
| http://dx.doi.org/10.11604/pamj.supp.2020.35.134.25011 | DOI Listing |
Publication Analysis
Top Keywords
[sars-cov-2 infection
4
infection patient
4
patient treated
4
treated hydroxychloroquine
4
hydroxychloroquine anti
4
anti tnf
4
tnf inflammatory
4
inflammatory rheumatic
4
rheumatic disease]
4
disease] hydroxychloroquine
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!